Wirksamkeit von hausstaubmilben- und allergendichten Encasings bei Patienten mit Hausstaubmilbenallergie
The DOI matches its Crossref record.
Abstract
The clinical impact of allergen tight mattress encasings has still been debated. Beside encasings, recommended measures include the use of HEPA filter in the vacuum cleaner, reducing the humidity by increased ventilation rate and weekly change of bed linen. Materials and methods: A double-blind, placebo-controlled crossover study was performed to evaluate the clinical efficacy of mattress covers (VarioProtect encasings, Sanders, Germany). We included 30 patients with rhinitis or asthma due to house dust mite allergy of which 26 completed the study. At an initial visit for evaluation of the inclusion criteria, patients received a hygrometer and were seen 4 additional times for blood sampling and delivery of the active cover and later the placebo cover (cotton cover) or vice versa. Both study phases lasted 9 - 11 weeks, the wash-out period in-between lasted 2 - 10 weeks to avoid any interference with pollen allergy. At the patients' homes, a study-independent person collected dust samples which were analyzed for house dust mite allergen using an immunodot assay with monoclonal antibodies against the house dust mite allergen Der p 1, Der f 1 and mite group 2. For the evaluation of allergen content, the sum of the 3 allergens was used. Serum eosinophil cationic protein was measured to define the underlying allergic inflammation. Subjective clinical complaints regarding rhinoconjunctivitis and asthma were asked using a standardized questionnaire by E. Juniper. All patients were informed to wash their bed linen weekly and to increase the level of air exchange. A score for medication intake was calculated and the sleeping comfort with the active or placebo covers was evaluated. Results: A statistically significant reduction of the allergen content from 1.43 μg/m 2 /2 min to 0.65 μg/m 2 /2 min was found after using the active cover, but not after using the placebo cover (1.49 μg/m 2 /2 min). The measurement of the relative humidity in the air revealed no change throughout the study. At the beginning of the study, 49.5% relative humidity was measured, at the end of the study in summer time 64.3% were measured. The clinical complaints did not significantly change comparing both groups (active/placebo or placebo/active). A carry-over effect could be excluded since baseline values were similar. Pooling all data for the subjective rhinitis score revealed a statistically significant decrease in all 26 patients receiving either placebo or active treatment. In 8 patients with an elevated serum ECP level (> 16 μg/l), an amelioration of rhinitis could be seen in the active phase compared to the placebo phase. In addition, 12 patients with asthma reported fewer symptoms using the active cover compared with the placebo cover. After the active cover phase, 6 of the 8 patients with elevated ECP had a lower level of ECP, while 6 patients with the placebo cover had a higher level of ECP (p < 0.025). The medication intake was reduced during the active phase as well as during the placebo phase. The general comfort using the active cover was good with the exception of some rustling. The data confirm the clinical efficacy of allergen impermeable covers: an allergen reduction as well as a clinical relieve can be achieved, whereby the patients with elevated ECP may be particularly susceptible to allergen avoidance measurements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While several studies have demonstrated decreased concentrations of environmental HDM antigens,1119-1124”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1120]
In the citing paper
“Despite reductions in HDM antigen concentration, Ghazala et al.1120 and Terreehorst et al.1124 both found no clinical benefits of HDM-impermeable bedding as an isolated intervention.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1120]
Citations
Cites
Still being checked.
Cited by
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
House dust mite control measures for asthma
Gøtzsche, P. C., & Johansen, H. K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001187.pub3 · Cited by 296
House dust mite control measures for asthma: systematic review
Gøtzsche, P. C., & Johansen, H. K. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01690.x · Cited by 166
House dust mite avoidance measures for perennial allergic rhinitis
Sheikh, A., Hurwitz, B., Nurmatov, U., & van Schayck, C. P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001563.pub3 · Cited by 164
Metadata
- Authors
- Ghazala, L., Schmid, F., Helbling, A., Pichler, W. J., & Pichler, C. E.
- Venue
- Allergologie
- Publisher
- Dustri-Verlgag Dr. Karl Feistle
- Published
- 2004-01-01
- Volume
- 27
- Issue
- 01
- Pages
- 26-34
- ISSN
- 0344-5062 (ISSN-L)
- OpenAlex
- W2022257446
- Cited by
- 14
- References
- 0
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2014: 2
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Allergologie (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Indoor Air Quality and Microbial Exposure
- Keywords
- house dust mite allergy, house dust mite allergens, Der p 1, Der f 1, allergen reduction, rhinitis, asthma, eosinophil cationic protein, allergic inflammation, rhinoconjunctivitis, sleep comfort, relative humidity, bed linens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wirksamkeit von hausstaubmilben- und allergendichten Encasings bei Patienten mit Hausstaubmilbenallergie. https://app.cochat.ai/papers/10.5414/alp27026
- The paper
- Ghazala, L., Schmid, F., Helbling, A., Pichler, W. J., & Pichler, C. E. (2004). Wirksamkeit von hausstaubmilben- und allergendichten Encasings bei Patienten mit Hausstaubmilbenallergie. Allergologie. https://doi.org/10.5414/alp27026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.